Clinical Trials Browser

Phase 1 × Terminated × EGFR-mutated NSCLC (Disorder) × Clear all

NCT03418532 2023-03-23

MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC

Phase 1 Terminated

EGFR-mutated NSCLC (Disorder)